Report: Sanofi will invest in Japanese firm to enter generics market

05/26/2010 | Reuters

Sanofi-Aventis will buy a stake of almost 5% in Japan's Nichi-Iko Pharmaceutical for about $55 million in a bid to enter the country's generic-drug market, according to a newspaper report. The companies also plan to create a joint venture and team up in developing bioengineered drugs, the report states.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX